CIENCIASMEDICASNEWS

lunes, 19 de octubre de 2026

Translating Molecular Insights Into Practice for HR-Positive/HER2-Negative Metastatic Breast Cancer Authors: Hope Rugo, MD; Peter A. Fasching, MD

https://www.medscape.org/viewarticle/translating-molecular-insights-practice-hr-positive-her2-2026a1000y0g?page=1&src=mkmcmr_driv_32025_mscpedu_451770.18_ace_launch&uac=148436CN

CURATIVE POTENTIAL NOW IN 2L DLBCL

https://global.columvi-hcp.com/?cid=na1191708001&utm_source=medscape&utm_medium=na&utm_campaign=columvi2026&utm_content=tx%3Aagenative%3A2603%3Axx&dclid=CjkKEQjw_9bWBhDiscOaku6CnKkBEiQAKCg80nE2km_tXx8jxv0bSnvbxCJY14soZkwxNvGTx15fUMTw_wcB&gad_source=7&gad_campaignid=23680757487 At 3 years, regardless of your patient’s age or relapse time in 2L DLBCL, COLUMVI + GemOx demonstrates sustained survival benefit. And it’s well tolerated. Be confident with the first and only approved off-the-shelf therapy with curative potential in 2L DLBCL https://www.medscape.com/invitation/viewTracker.do?src=inve&uac=148436CN

PHESGO: Proven efficacy and a convenient method of administration Subcutaneous administration in minutes, without compromising on efficacy

HER2-targeted therapies have transformed the HER2+ breast cancer landscape Give your patients a proven treatment approach that balances efficacy with well-established safety profiles, keeping your patients' quality of life at the centre of your treatment approach. https://global.phesgo-hcp.com/?cid=na7759503509&utm_source=medscape&utm_medium=na&utm_campaign=her2_2026&utm_content=tx%3Aphesgonc5%3A2609%3Axx&dclid=CjkKEQjw_9bWBhDiscOaku6CnKkBEiQAKCg80ktc7Kj_Slf6KPtBQnPnT8UVfo34wD9aElkpGuCBeofw_wcB&gad_source=7

Reshaping Gastroesophageal Adenocarcinoma Care: Integrating New Anti-HER2 Therapies CME/CNE/CPE/IPCE Monday, November 9, 2026 | 3:30 pm - 4:15 pm ET Virtual

https://na.eventscloud.com/website/99132/ Transform your gastroesophageal adenocarcinoma (GEA) practice by joining expert oncologists Elena Elimova, Samuel J. Klempner, and Kohei Shitara for an interactive, 45-minute online discussion. Unpack the latest clinical trial data for novel anti-human epidermal growth factor receptor 2 (HER2) regimens, learn how to integrate new frontline regimens into care for patients with HER2-positive GEA, and gain insight into postprogression strategies. Faculty will also discuss proactive team-based approaches to toxicity management. Register now to elevate your clinical decision-making.

The Fifth Transatlantic Exchange in Oncology: Transatlantic Innovations in Cancer Drug Research – A Selection of Key Presentations From the Event (video series)

https://www.medscape.com/medicalaffairs/448002.4/media-5?src=0_nl_sm_0&uac=148436CN The Fifth Annual Transatlantic Exchange in Oncology reflects an ongoing collaboration between key scientists, clinicians, and researchers from the Institut Gustave Roussy in Villejuif, France and Dana-Farber Cancer Institute (DFCI) in Boston, USA (supported by L’Institut Servier). This year’s event brought together a global audience with expertise in medical oncology, translational research, and molecular biology to exchange and discuss insights and new developments in the rapidly evolving area of cancer drug research. The event was held in Boston – at the Jimmy Fund Auditorium at DFCI - on March 27, 2026. Prof Eric Fischer from DFCI gave his insights on the day with this short “Expert Commentary” on the program. Prof Toni Choueiri then provides the Welcome Address. This is followed by 4 videos from the day’s events which reflect the depth and diversity of cancer drug research and collaboration across the Atlantic.

The Rock's protein-heavy post-workout smoothie may not be right for everyone

The Rock's protein-heavy post-workout smoothie may not be right for everyone https://www.foxnews.com/lifestyle The Rock's protein-heavy post-workout smoothie may not be right for everyone Dietitian says star's protein-packed drink offers nutritional benefits, but some ingredients may be excessive for others By Sadie Chafe Fox News Published October 19, 2026 6:00am EDT | Updated October 19, 2026 6:30am EDT https://www.foxnews.com/food-drink/rocks-protein-heavy-post-workout-smoothie-may-not-right-everyone